Chon et al. reported that CRC patients with high tumor cell-intrinsic STING expression exhibited increased CD8+ tumor-infiltrating lymphocytes (TILs) and better clinical outcomes compared to those with low tumor cell-intrinsic STING expression14. The gene discussed is STING1; the disease is colorectal carcinoma.